Product image of Nofrattil (Alendronic Acid) supplied by GNH India

Nofrattil

Active Ingredient:
Alendronic Acid
Origin:
EU

Nofrattil (Alendronic Acid)

Alendronic Acid, the active ingredient in Nofrattil, is a bisphosphonate presented as an oral tablet for oral use. It is employed to treat osteoporosis in postmenopausal women, to prevent osteoporotic fractures, and to manage Paget's disease of bone.

GNH India supplies Nofrattil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards, maintains regulatory certifications, and provides reliable logistics for cross‑border distribution. Our network ensures timely delivery and supports pharmacovigilance activities in partner institutions.

Manufacturer / TM Owner

S.F. Group Srl

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nofrattil, a bisphosphonate, is indicated for conditions involving excessive bone resorption.

  • Osteoporosis in postmenopausal women: reduces bone loss and lowers fracture risk.
  • Prevention of osteoporotic fractures: strengthens bone density to help avoid vertebral and hip fractures.
  • Paget's disease of bone: normalizes abnormal bone remodeling and alleviates associated pain.

How It Works

  • Alendronic Acid binds selectively to hydroxyapatite crystals on bone surfaces, especially at sites of active remodeling. When osteoclasts attach to the drug‑coated bone, the bisphosphonate is internalized, inhibiting the enzyme farnesyl pyrophosphate synthase within the mevalonate pathway. This disruption induces osteoclast apoptosis, thereby decreasing bone resorption and allowing bone formation to predominate. The effect persists for months because the drug remains bound to bone matrix, providing prolonged inhibition of resorption.

Side Effects

Alendronic Acid may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Gastrointestinal irritation: abdominal discomfort, dyspepsia, or nausea.
  • Esophageal discomfort: heartburn or difficulty swallowing.
  • Musculoskeletal pain: bone, joint, or muscle aches.
  • Flu‑like symptoms: transient fever or fatigue after the first dose.

Serious or Rare Side Effects

  • Osteonecrosis of the jaw: exposed bone and pain in the jaw area.
  • Atypical femur fracture: sudden thigh or groin pain with possible fracture.
  • Severe esophageal ulceration or stricture: persistent pain or bleeding.
  • Hypocalcemia: low blood calcium levels causing muscle cramps or tingling.
  • Acute renal impairment: sudden decrease in kidney function.
  • Anaphylactic reaction: hives, swelling, or difficulty breathing.

Precautions & Warnings

Before prescribing Nofrattil, clinicians should consider several precautionary measures to minimize risk.

  • Assess renal function: ensure creatinine clearance meets recommended limits.
  • Verify calcium and vitamin D intake: adequate supplementation reduces hypocalcemia risk.
  • Instruct on administration: swallow tablet with a full glass of water on an empty stomach.
  • Avoid lying down: remain upright for at least 30 minutes after dosing.
  • Review concomitant medications: consider potential interactions with antacids or supplements.
  • Monitor for esophageal symptoms: discontinue if persistent pain or difficulty swallowing occurs.
  • Store below 25°C: keep in the original packaging, protect from moisture and heat.

Avoid Interactions

Alendronic Acid can interact with other medicines, affecting absorption or safety.

Major Interactions (Avoid)

  • Calcium, iron, magnesium, or antacid supplements taken within 30 minutes: markedly reduce drug absorption.
  • Concurrent use of other bisphosphonates or potent bone‑resorbing agents: increase risk of oversuppression.
  • Systemic corticosteroids combined with oral bisphosphonates: heightened chance of osteonecrosis of the jaw.

Moderate Interactions (Monitor Closely)

  • Aminoglycoside antibiotics: may exacerbate renal toxicity.
  • Loop diuretics: can alter calcium balance, requiring monitoring.
  • Warfarin: potential for fluctuating INR values, necessitating closer coagulation checks.

Frequently Asked Questions

Nofrattil contains Alendronic Acid, a bisphosphonate indicated for the treatment of osteoporosis in postmenopausal women, for preventing osteoporotic fractures, and for managing Paget's disease of bone by reducing excessive bone resorption.

Alendronic Acid binds to bone mineral at sites of active remodeling. When osteoclasts attach, the drug is taken up and inhibits farnesyl pyrophosphate synthase, a key enzyme in the mevalonate pathway, leading to osteoclast apoptosis and reduced bone resorption.

The prescribed dose of Nofrattil is individualized by the treating physician based on the patient’s diagnosis, renal function, calcium/vitamin D status, and overall risk profile. Exact dosing regimens are not disclosed here and should follow the prescriber’s instructions.

Safety data for Alendronic Acid in pregnancy and lactation are limited. It is generally classified as contraindicated or used only when the potential benefit outweighs the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To request Nofrattil, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nofrattil (Alendronic Acid) is a first‑line oral bisphosphonate with a well‑established efficacy profile. Compared with newer agents such as denosumab or injectable bisphosphonates, it offers a convenient oral route but may have higher gastrointestinal tolerability concerns. Choice of therapy depends on patient preference, comorbidities, and risk assessment.

Nofrattil tablets should be stored below 25 °C in their original blister pack, protected from moisture and direct heat. Keep the container tightly closed and out of reach of children. Do not refrigerate or expose the product to excessive humidity.

Nofrattil is taken orally, preferably with a full glass of water on an empty stomach. Patients should remain upright for at least 30 minutes after swallowing the tablet and avoid eating, drinking, or taking other medications during that time to ensure optimal absorption.

Serious adverse events include osteonecrosis of the jaw, atypical femur fractures, severe esophageal ulceration or stricture, acute renal impairment, and rare anaphylactic reactions. Patients should be monitored for persistent jaw pain, unusual thigh pain, swallowing difficulties, or sudden changes in kidney function.

Nofrattil is contraindicated in individuals with known hypersensitivity to Alendronic Acid or other bisphosphonates, severe renal impairment (creatinine clearance <30 mL/min), esophageal disorders that delay emptying, and those unable to remain upright after dosing. Caution is also advised for patients on concurrent corticosteroid therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Alendronic Acid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT